Old Web
English
Sign In
Acemap
>
authorDetail
>
R. Deurloo
R. Deurloo
Humanities
Pathology
Bevacizumab
HER2 negative
Oncology
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Zeventien miljoen stippen op een kaart - een kritisch commentaar
2017
Geografie
R. Deurloo
S. Musterd
Show All
Source
Cite
Save
Citations (0)
Exploratory analyses of candidate predictive and prognostic tissue biomarkers (BMs) in the open-label randomised phase III TANIA trial of bevacizumab (BEV) in HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
2016
Annals of Oncology
Christoph Zielinski
J. Gligorov
N. Marschner
Fabio Puglisi
Eduard Vrdoljak
J. Cortes Castan
S. de Ducla
R. Deurloo
V. Easton
G. von Minckwitz
Show All
Source
Cite
Save
Citations (0)
SIGIL: A Novel GNSS/INS Integration for Challenging Environment
2013
J-B. Lacambre
M-L. Duplaquet
J-M. Louge
Y. Paturel
R. Deurloo
F. Boon
K. Smolders
B. Bougard
Show All
Source
Cite
Save
Citations (0)
Stadsmonitor Amsterdam en ruimtelijke plannen
2002
R. Deurloo
K. Dignum
Show All
Source
Cite
Save
Citations (0)
1